GSK came out with its annual accounts last night. R&D spend note was only 4 cells will be culled and 3 new ones added. As long as it was not OBJ then all looks good. Someone in the know would be aware of who got culled
growing market interest, page-21
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable